New imaging technique aims to sharpen prostate cancer radiation

NCT ID NCT07393867

First seen Feb 06, 2026 · Last updated May 15, 2026 · Updated 14 times

Summary

This study is for men with intermediate- or high-risk prostate cancer who will receive hormone therapy and radiation. Researchers want to see if a special scan taken during hormone therapy can help doctors better target the remaining cancer with radiation, while avoiding healthy areas. About 23 participants will get standard treatment plus three scans over six months. The goal is to make radiation more precise and reduce side effects for future patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, 02115, United States

  • Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center

    Milford, Massachusetts, 01757, United States

  • Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital

    Weymouth, Massachusetts, 02190, United States

Conditions

Explore the condition pages connected to this study.